Key result
Transthoracic echocardiography plays a pivotal role in the screening and follow-up of TAVI patients, though it has limitations in annulus sizing and grading paravalvular regurgitation.
Answers are grounded in this paper and cite their sources.
Highlights the pivotal role of transthoracic echocardiography (TTE) in the pre-procedural planning and post-procedural follow-up of TAVI.
Transcatheter aortic valve implantation (TAVI) has undeniably revolutionised the field of interventional cardiology regarding the treatment of aortic stenosis (AS). With promising outcomes from the recently published PARTNER 2 trial (1), involving patients at intermediate risk for surgical treatment, further growth of an already rapidly expanding field is expected. Echocardiography has a pivotal role in transcatheter therapies from the early steps when the clinical diagnosis of a valvular disease is made to the postprocedural long-term follow-up. Although the role of transoesophageal echocardiography (TOE) for either pre-procedural planning or intraoperative guidance in TAVI has been the subject of several reviews and debates, the role of the older member of the family, transthoracic echocardiography (TTE), has not been given the attention it deserves. In this issue of Echo Research and Practice, Fryearson and coworkers review the role of TTE before and following TAVI and discuss as how it helps inform clinical decision-making in TAVI (2).
No takes yet. Share an insight, caveat, or question.
Eskandari et al. (2016) conducted an editorial in Aortic stenosis undergoing TAVI. Transthoracic echocardiography (TTE) was evaluated. Transthoracic echocardiography plays a pivotal role in the screening and follow-up of TAVI patients, though it has limitations in annulus sizing and grading paravalvular regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: